{"id":49456,"date":"2024-04-26T09:00:00","date_gmt":"2024-04-26T09:00:00","guid":{"rendered":"https:\/\/setterwalls.se\/?post_type=assignments&#038;p=49456"},"modified":"2024-04-26T09:02:21","modified_gmt":"2024-04-26T09:02:21","slug":"setterwalls-has-assisted-kkr-in-connection-with-the-acquisition-of-immedica-pharma","status":"publish","type":"assignments","link":"https:\/\/setterwalls.se\/en\/case\/setterwalls-has-assisted-kkr-in-connection-with-the-acquisition-of-immedica-pharma\/","title":{"rendered":"Setterwalls has assisted KKR in connection with the acquisition of Immedica Pharma"},"content":{"rendered":"    <section class=\"block text \">\n        <div class=\"container container-sm\">\n            <div class=\"row\">\n                <div class=\"col-12\">\n                    <div class=\"editor-content\">\n                                                <p>Funds managed by KKR have agreed to acquire Immedica Pharma. The existing owner, the Nordic investment company Impilo, will reinvest and enter into a strategic partnership with KKR. The transaction is subject to customary conditions.<\/p>\n<p>Immedica was founded in 2018 by Impilo and an experienced management team with a strong track record of launching and commercializing drugs for rare diseases in Europe. The company has built up a portfolio and pipeline of drugs, primarily within hematology\/oncology as well as genetic and metabolic diseases for rare conditions with a high medical need. Immedica has rapidly expanded to become a prominent player in the field of rare diseases in Europe, with revenues of EUR 100 million and an annual growth of more than 50%.<\/p>\n<p>The investment is made through KKR Health Care Strategic Growth Fund II, which focuses on investments in fast-growing healthcare companies. KKR has a long history of supporting healthcare companies globally and has invested approximately 20 billion dollars in the sector since 2004.<\/p>\n<p>Bank of America Securities acted as financial advisor. Gibson Dunn, Setterwalls and Cooley acted as legal advisors. Alvarez &amp; Marsal and PwC acted as financial and tax advisors, and Clearview Healthcare Partners assisted as commercial advisor.<\/p>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"featured_media":48509,"template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":""},"class_list":["post-49456","assignments","type-assignments","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments\/49456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments"}],"about":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/types\/assignments"}],"author":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/users\/11"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media\/48509"}],"wp:attachment":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media?parent=49456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}